Steno Diabetes Center Aarhus

What Steno Diabetes Center Aarhus does

Steno Diabetes Center Aarhus (SDCA) is a public healthcare and research institution established in 2018 and operated by Region Midtjylland, with clinical operations housed in the Forum building at Aarhus Universitetshospital since September 2022. The center delivers specialized diabetes care to patients in Region Midtjylland across type 1, type 2, and early-onset type 2 diabetes, integrating treatment with clinical research and professional education. It is one of five regional Steno Diabetes Centers in Denmark, working alongside peer centers in Sjælland, Hovedstaden, and elsewhere.

The center's digital product portfolio centers on two proprietary platforms. SAMBLIK-diabetes is a cross-sector IT solution that aggregates patient data from hospitals, general practice, municipalities, the laboratory portal, and the Common Medicine Card, giving clinicians a single overview of treatment history, goals, and contacts; it has been co-financed by the Ministry of Health and deployed across Region Midtjylland, Region Sjælland, and Region Hovedstaden. INDBLIK is a remote monitoring tool that automatically retrieves blood sugar sensor data and surfaces alerts to clinicians. A 2026 addition is a digital decision-support tool for diabetes management during surgery, alongside a 2EARLY research program targeting early-onset type 2 diabetes. Professional education is delivered through a national 3-day insulin pump and glucose sensor course (3,000 DKK), the Diabetesforskerne podcast, and recurring seminars.

SDCA is a non-commercial public institution funded by the Danish regional healthcare system through Region Midtjylland, supplemented by research grants from Novo Nordisk Fonden (cumulative grants include 50M DKK for adipose tissue research, 25M DKK for INTEN-CT, 5M DKK for evening meal research), Kræftens Bekæmpelse (~5M DKK), Danmarks Frie Forskningsfond (1.5M DKK), and the Task force pool for chronic disease and inequality (3.9M DKK for SAMBLIK). Customer segments are individuals with diabetes in Region Midtjylland, healthcare professionals across hospitals, general practice, and municipalities, and academic research collaborators. With ~184 multidisciplinary staff, the center operates at the intersection of clinical care, applied research, and digital health innovation within the Danish public system.

Name

Steno Diabetes Center Aarhus

Legal name

Steno Diabetes Center Aarhus

Website

https://stenoaarhus.dk

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

Steno Diabetes Center Aarhus is a public diabetes treatment, research, and education center operated by Region Midtjylland in Aarhus, Denmark, serving diabetes patients and healthcare professionals through clinical care, proprietary digital health platforms (SAMBLIK, INDBLIK), and multidisciplinary research programs.

Ownership category

akta.pro rank

Product category

Diabetes Healthcare Services

NAICS

Offices of Physicians (62111), Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

akta.pro secondary industries

Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)

Keywords

• Diabetes care services
• Diabetes clinical research
• Digital health platforms
• Remote patient monitoring
• Professional diabetes education

Headquarters

HQ city

Aarhus N

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Public Healthcare Services: As a public healthcare institution under Region Midtjylland, Steno Diabetes Center Aarhus is funded through the Danish public healthcare system. Services are provided as part of the regional healthcare infrastructure and are covered by public taxation.
2. Research Grants and External Funding: The center receives research funding from Novo Nordisk Fonden (50 million DKK for fat tissue research, 5 million DKK for evening meal research, 25 million DKK for INTEN-CT study, plus other grants), Danmarks Frie Forskningsfond (1.5 million DKK for exercise research), Kræftens Bekæmpelse (approximately 5 million DKK for diabetes-cancer research), and other research foundations. Development of SAMBLIK was co-financed by the Ministry of Health.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Steno Diabetes Center Aarhus is a public healthcare and research institution that provides specialized diabetes treatment, clinical research, and professional education under Denmark's Region Midtjylland. It develops and operates digital health platforms (SAMBLIK-diabetes, INDBLIK) for cross-sector care coordination and remote patient monitoring, and delivers clinical consultations, training courses, and multidisciplinary research programs focused on type 1 and type 2 diabetes.

Product overview

Steno Diabetes Center Aarhus is a diabetes treatment, research, and education center offering a portfolio of digital health products and services. The core digital offerings include SAMBLIK-diabetes (a cross-sector data aggregation platform) and INDBLIK (a remote monitoring and need-based treatment tool). Additional services include professional training courses for diabetes technology, educational podcasts, and multidisciplinary research programs. The center functions as an integrated part of Aarhus University Hospital, combining clinical care with research, innovation, and knowledge sharing.

Differentiator

Problem solved

Functional benefit

Brands

• SAMBLIK: A digital IT solution that provides healthcare providers across sectors with the same overview of patients' disease history. Originally developed for type 2 diabetes patients and now being expanded to other disease areas.
• INDBLIK

Products and services

• SAMBLIK-diabetes A digital platform that aggregates patient data from multiple healthcare sectors (hospitals, general practice, municipalities) to provide healthcare professionals with a shared overview of treatment history, treatment goals, contacts with the healthcare system, and disease picture for persons with type 2 diabetes.
• INDBLIK A digital tool that automatically retrieves blood sugar data from patient sensors, presents it clearly to clinicians, and sends alerts for deviations or attention points in the patient's treatment course, supporting more differentiated and needs-based diabetes treatment.
• Digital Decision Tool for Diabetes and Surgery A digital decision-support tool for managing diabetes patients undergoing surgery that assists with calculations of medication doses and intervals for blood sugar measurements, providing more safety for staff and patients during surgical procedures.
• Insulin Pump and Glucose Sensor Training Course A national 3-day course for doctors, nurses, and dietitians involved in diabetes treatment with insulin pumps and glucose sensors. Healthcare professionals wear insulin pumps and glucose sensors during the course to better understand the patient experience.
• Diabetesforskerne (The Diabetes Researchers) Podcast

Quantifiable outcome

• Nearly 75% of people with type 2 diabetes in Denmark are well-treated
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Danish Cancer Comprehensive Center (DCCC)minorStrategic or Co-development Partner · 1 January 2025Collaboration on SAMBLIK-Kræft concept development, which was mentioned in the Danish Cancer Plan V proposal.
• Minnesota UniversityminorStrategic or Co-development Partner · 1 January 2025International collaboration on the 5 million DKK evening meal research project studying effects on metabolism and inflammation.
• Nationalt Center for Overvægt (National Center for Obesity)minorStrategic or Co-development Partner · 1 January 2025Collaboration on conference 'Skal vi medicinere os ud af svær overvægt?' and training video development for exercise with obesity.
• Steno Diabetes Center SjællandcoreStrategic or Co-development Partner · 1 January 2024Collaboration on SAMBLIK-diabetes large-scale testing across multiple regions. Joint implementation of cross-sector digital health solution.
• Steno Diabetes Center HovedstadencoreStrategic or Co-development Partner · 1 January 2024Collaboration on SAMBLIK-diabetes large-scale testing across multiple regions. Joint implementation of cross-sector digital health solution.
• Aarhus UniversitetcoreStrategic or Co-development Partner · 1 January 2022Academic partnership for research collaboration. Multiple researchers hold positions at both institutions. Joint research projects including the 50 million DKK Novo Nordisk Fonden grant for adipose tissue research.
• SundhedsdatastyrelsencoreStrategic or Co-development Partner · 1 January 2022SAMBLIK program oversight and governance. The Program Steering Group for 'Et Samlet Patientoverblik' serves as steering group for SAMBLIK implementation.
• Sundhedsministeriet (Ministry of Health)coreStrategic or Co-development Partner · 1 January 2022Co-financed the development of SAMBLIK-diabetes through grant funds. Active in supporting digital health innovation for chronic disease management.

Scale indicators9 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• Steno Diabetes Center Copenhagen (Steno Diabetes Center Hovedstaden): Sister Steno Diabetes Center serving Region Hovedstaden. Directly comparable model: public specialty/research center for diabetes with cross-sector digital tools, joint pilot partner with Steno Aarhus on SAMBLIK-diabetes.
• Steno Diabetes Center Nordjylland: Steno Diabetes Center in Region Nordjylland. Same mandate, funding model, and digital health innovation focus; part of the national Steno network that jointly competes and collaborates with Steno Aarhus.
• Steno Diabetes Center Sjælland: Regional Steno Diabetes Center in Region Sjælland. Same institutional model, joint SAMBLIK-diabetes rollout partner, and competing center for Danish diabetes research and clinical capacity.
• Joslin Diabetes Center: Harvard-affiliated US diabetes research and clinical center. International analogue combining specialist care, research, and provider education; provides benchmark for translational diabetes research output.
• Steno Diabetes Center Odense: Steno Diabetes Center serving Region Syddanmark. Same operating model combining clinical care, research, and education; competing for national research funding and talent.

Others

• Danish Diabetes and Endocrine Academy (DDEA): National training and research networking body for diabetes/endocrinology. Awards and networking infrastructure referenced in Steno Aarhus's research output; helps cultivate talent pool.
• Danmarks Nationale Diabetesregister (Danish Diabetes Association): National patient advocacy organization. Ecosystem participant that shapes political/public agendas for diabetes care in Denmark and influences the demand for Steno Aarhus's education and outreach.

Broad incumbents

• Aarhus Universitetshospital: Host hospital and broader clinical/research institution in which Steno Diabetes Center Aarhus is physically and operationally embedded. Provides shared infrastructure, multidisciplinary talent, and inpatient capacity.
• Novo Nordisk Foundation Center for Basic Metabolic Research: University of Copenhagen research center funded by Novo Nordisk Foundation. Comparable translational diabetes/metabolic research mandate; shares research funding pool with Steno Aarhus.

Regional players

• Diabetes UK: UK national diabetes charity and research funder. International peer in patient advocacy, research funding, and provider education; not a direct competitor but operates a similar model in a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/SDCAarhus
• LinkedInlinkedin.com/company/steno-diabetes-center-aarhus

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Steno Diabetes Center Aarhus